| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29e239c86a5934daefc895b6f1cc10f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39a9f66181ba753d515b2c2ef8e707da |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2008-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f483032b4c8d478daa1bbec6a9b9804b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da1d8b2c7aec354b47efea60e276526d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2837d58339c5ccc8583aebf8bf92048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd8968a289190a435640d31d1082e27b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2489db18d4c9fdbbf1c74ebfdcda38a3 |
| publicationDate |
2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010111631-A |
| titleOfInvention |
Therapeutic agent for ischemic cardiovascular disease |
| abstract |
Disclosed is a novel therapeutic angiogenesis therapy useful for the treatment of ischemic cardiovascular diseases. The present invention provides the following means: a polypeptide comprising an amino acid sequence of the extramembrane region of plexin D1, which is a specific receptor for semaphorin 3E, and an amino acid sequence having homology with the amino acid sequence. A therapeutic agent for ischemic cardiovascular disease comprising a polypeptide, and a polypeptide selected from a polypeptide comprising any of the aforementioned polypeptides, wherein the polynucleotide has an action of inhibiting the angiogenesis inhibitory action of semaphorin 3E An angiogenesis-promoting agent; a therapeutic agent for ischemic cardiovascular disease comprising a polynucleotide encoding any one of the aforementioned polypeptides; and an angiogenesis-promoting agent; and administering the polypeptide or the polynucleotide to a subject A method for treating ischemic cardiovascular disease, a method for promoting angiogenesis, and a blood vessel of semaphorin 3E Method of identifying a compound having an effect of inhibiting the raw inhibitory effect. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2941270-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012087066-A |
| priorityDate |
2008-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |